WSG-ADAPT TN: Neoadjuvant Albumin-Bound Paclitaxel + Carboplatin or Gemcitabine in TNBC

Slideset - In patients with triple-negative breast cancer, 12 weeks of albumin-bound paclitaxel plus carboplatin significantly increased pCR rate vs albumin-bound paclitaxel plus gemcitabine.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research